SeaStar Medical Holding Corporation (ICU)
NASDAQ: ICU · Real-Time Price · USD
0.6022
-0.0061 (-1.00%)
At close: Sep 26, 2025, 4:00 PM EDT
0.6099
+0.0077 (1.28%)
After-hours: Sep 26, 2025, 7:59 PM EDT
SeaStar Medical Holding Employees
SeaStar Medical Holding had 19 employees as of December 31, 2024. The number of employees increased by 7 or 58.33% compared to the previous year.
Employees
19
Change (1Y)
7
Growth (1Y)
58.33%
Revenue / Employee
$40,316
Profits / Employee
-$772,158
Market Cap
16.81M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 19 | 7 | 58.33% |
| Dec 31, 2023 | 12 | 3 | 33.33% |
| Dec 31, 2022 | 9 | 6 | 200.00% |
| Dec 31, 2021 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ICU News
- 3 days ago - SeaStar Medical Reports DSMB Recommendation to Continue the NEUTRALIZE-AKI Pivotal Trial in Adult Acute Kidney Injury - GlobeNewsWire
- 4 days ago - SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children - GlobeNewsWire
- 23 days ago - SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 25 days ago - SeaStar Medical Announces Newly Published QUELIMMUNE Health Economic Study Projecting Significantly Reduced Health Care Costs in the Treatment of Pediatric AKI due to Estimated Shorter Hospital Stays and Increased Survival - GlobeNewsWire
- 6 weeks ago - SeaStar Medical Reports Second Quarter 2025 Financial Results and Provides Business Updates - GlobeNewsWire
- 7 weeks ago - SeaStar Medical to Report Second Quarter Financial Results on August 13, 2025 - GlobeNewsWire
- 7 weeks ago - SeaStar Medical Reaches New Enrollment Milestone in NEUTRALIZE-AKI Pivotal Trial of SCD Therapy for Adult Patients with Acute Kidney Injury (AKI) - GlobeNewsWire
- 2 months ago - SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire